114
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Budgetary impact analysis of alteplase - recombinant tissue plasminogen activator (rtPA) - as a thrombolytic treatment for acute ischemic stroke in Colombia

&
Pages 1095-1102 | Received 10 Aug 2021, Accepted 10 Jun 2022, Published online: 16 Jun 2022

References

  • Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113–130.
  • Donkor ES. Stroke in the century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:1–10.
  • Campbell B, De Silva D, Macleod M, et al. Ischaemic stroke. Nat Rev Dis Prim. 2019;5(1). DOI:10.1038/s41572-019-0118-8.
  • Teasell R, Foley NC, Bhogal SK, et al. An Evidence-Based Review of Stroke Rehabilitation. Topics in Stroke Rehabilitation. 2003;10(1);29–58.
  • Feigin VL, Nguyen G, Cercy K. The GBD 2016 lifetime risk of stroke collaborators. global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429–2437.
  • Johnson CO, Nguyen M, Roth GA, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–458.
  • Reyes AM, García V, Torres I, et al. Actualización en diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo. Univ Medica. 2019;60:3–5.
  • Ministerio de Salud, Dirección de Epidemiología y Demografía. Análisis de Situación de Salud (ASIS) 2018 (Bogotá, Colombia: Ministerio de Salud). 2018. p. 264.
  • Institute for Health Metrics and Evaluation (IHME). global burden of disease compare data visualization. Seattle, WA IHME, Univ. Washingt. 2019.
  • Bayona-Ortiz H, Useche JN, Yanez N, et al. Availability of stroke units in Colombia. Lancet Neurol Internet]. 2019;18(11) :988.
  • Suárez-Escudero JC, Restrepo Cano SC, Ramírez EP, et al. Descripción clínica, social, laboral y de la percepción funcional individual en pacientes con ataque cerebrovascular. Acta Neurológica Colomb. 2011;27:97–105.
  • Rajsic S, Gothe H, Borba HH, et al. Economic burden of stroke: a systematic review on post-stroke care. Eur J Heal Econ. 2019;20(1):107–134.
  • Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–1329.
  • McDermott M, Skolarus L, Burke J. A systematic review of interventions to increase tPA administration. Stroke. 2016;47(suppl_1):1–10.
  • Uribe C, Jiménez I, Mora M, et al. Epidemiology of cerebrovascular diseases in Sabaneta, Colombia (1992-1993). Rev Neurol. 1997;25(143):1008–1012.
  • Saposnik G, Del Brutto OH. Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke. 2003;34(9):2103–2107.
  • Sudlow CLM, Warlow CP. Comparable studies of the incidence of stroke and its pathological types. Stroke. 1997;28(3):491–499.
  • Feigin VL, Lawes CMM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43–53.
  • Departamento Administrativo Nacional de Estadísticas (DANE). Proyecciones y retroproyecciones de población nacional para el periodo 1950-2017 y 2018-2070 con base en el CNPV 2018 (Bogotá, Colombia: Departamento Administrativo Nacional de Estadística). 2020.
  • Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA. Consulta de registros sanitarios (Bogotá, Colombia: Instituto Nacional de Vigilancia de Medicamentos y Alimentos). 2020.
  • Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 375(9727): 1695–1703. 2010.
  • Group TNI of ND and S rt-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–1588.
  • Frank B, Grotta JC, Alexandrov AV, et al. Thrombolysis in Stroke Despite Contraindications or Warnings? Stroke. 2013;44(3):727–733.
  • Ministerio de Salud y Protección Social (MSPS). Cubo de Suficiencia UPC. Consulta para el periodo 2016-2019. 2021 June 10; 2021.
  • Silva-Sieger FA, Arenas-Borda W, Zarruk-Serrano JG, et al. Factors associated to the visiting time in patients with ischaemic cerebrovascular disease. Rev Neurol. 2007;44(5):259–264.
  • Instituto de Evaluación Tecnológica en Salud. IETS. Manual para la elaboración de evaluaciones económicas en salud. Bogotá D.C: IETS; 2014.
  • Ministerio de Salud y Protección Social (MSPS). Sismed - Sistema de información de precios de medicamentos. Reporte 2020. [Internet]. 2021 cited 2021 Apr 10]. Available from 2021 Apr 10: http://www.sispro.gov.co/recursosapp/app/Pages/Precios de Medicamentos Circular 2 de 2012 Excel.aspx. de Medicamentos Circular 2 de 2012 Excel.aspx.
  • Ministerio de Salud y de la Proteccion Social. Circular 10 de 2020. Por la cual se unifica y se adiciona el listado de los medicamentos sujetos al régimen de control directo de precios, se fija su precio máximo de venta, se actualiza el precio de algunos medicamentos conforme al Índice de precios [Internet]. 2020 cited 2021 Apr 10]. Available from 2021 Apr 10: http://minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/circular-10-de-2020.pdf.
  • Dawson J, Lees JS, Chang T-P, et al. Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke. 2007;38(6):1893–1898.
  • Agencia española de medicamentos y productos sanitarios (AEMPS). Ficha técnica: alteplase (Actilyse) (Madrid, España. Agencia: Española de Medicamentos y Productos Sanitarios). 2019.
  • Bayona H, Martínez C, Guio C, et al. Usefulness of stroke coding in patients suffering from acute ischemic stroke: comparison between two time periods. Acta Neurol Colomb. 2014;30:256–262.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.